Seeking Alpha

Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back...

Allergan (AGN +0.6%) moves up a bit today after JMP Securities ups the shares to Buy on the back of its Q4 results, and Stifel Nicolaus reiterated its Buy rating and raised its price target from $110 to $118. Stifel notes that 2013 guidance was actually robust, and strength can be seen in all its business lines, namely Botox with iOAB launch. Read more on AGN's earnings call here: Earnings Call Transcript.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector